NCT01686672 Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis Status COMPLETED Phase NA
NCT01685801 Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function Status COMPLETED Phase PHASE2
NCT01684410 Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT01667094 A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis Status UNKNOWN Phase PHASE4
NCT01661491 Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis Status COMPLETED Phase N/A
NCT01658449 Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients Status COMPLETED Phase NA
NCT01651455 Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000 Status COMPLETED Phase N/A
NCT01641822 Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF Status COMPLETED Phase PHASE3
NCT01626157 A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF) Status COMPLETED Phase N/A
NCT01616862 The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis Status COMPLETED Phase N/A
NCT01615484 Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability Status COMPLETED Phase NA
NCT01614470 Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have a Non-G551D CF Transmembrane Conductance Regulator (CFTR) Gating Mutation Status COMPLETED Phase PHASE3
NCT01614457 Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT) Status COMPLETED Phase PHASE3
NCT01608555 Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT01605565 Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis Status COMPLETED Phase NA
NCT01594827 Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) Status COMPLETED Phase PHASE2